You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adrenergic alpha-Agonists

Showing 1 - 25 of 4,103
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Delirium, Cognitive Decline, Frailty Trial in Bergen, Oslo, Trondheim (Dexmedetomidine, Clonidine, Natriumchlorid)

Recruiting
  • Delirium
  • +2 more
  • Bergen, Norway
  • +3 more
Apr 25, 2022

Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

Recruiting
  • Glaucoma, Suspect
  • Aberration, Corneal Wavefront
  • Low dosage selective alpha-2 receptor agonists topical eyedrop
  • High dosage selective alpha-2 receptor agonists topical eyedrop
  • Banhā, QA, Egypt
    Ahmed Abdelshafy
Jan 2, 2023

Pheochromocytoma, Paraganglioma, Adrenalectomy; Status Trial in Seoul (Phenoxybenzamine)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 18, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • (no location specified)
Nov 28, 2023

Outcome Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Outcome
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Adverse Effect Trial (Alpha-Agonist, a-adrenergic receptor agonist)

Not yet recruiting
  • Adverse Effect
  • (no location specified)
Nov 28, 2023

Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or

Completed
  • Alcohol Withdrawal Syndrome
  • BZDP-Sparing Protocol
  • BZDP-Based Protocol
  • Stanford, California
    Stanford Hospital and Clinics
Jun 24, 2022

Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • BXCL501 (180 micrograms)
  • +3 more
  • (no location specified)
Jan 24, 2023

Voiding Disorders, Overactive Bladder Trial (Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin)

Not yet recruiting
  • Voiding Disorders
  • Overactive Bladder
  • Beta3-Agonists, Adrenergic
  • Anticholinergic drug, Solifenacin
  • (no location specified)
Feb 13, 2022

Insulin Resistance, Healthy, Obesity Trial in Nashville (Phentolamine, Saline, Sodium Nitroprusside)

Recruiting
  • Insulin Resistance
  • +2 more
  • Nashville, Tennessee
    Autonomic Dysfunction Center
Jan 2, 2023

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])

Not yet recruiting
  • Urgency Urinary Incontinence
  • Beta3-Agonists, Adrenergic
  • OnabotulinumtoxinA 100 UNT [Botox]
  • Birmingham, Alabama
  • +4 more
Mar 28, 2023

Symptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease Trial in Los Angeles (Terazosin

Recruiting
  • Symptomatic Parkinson Disease
  • +2 more
  • Terazosin therapy
  • Los Angeles, California
    Cedars Sinai Medical Center
Aug 23, 2022

Healthy Volunteers Trial in New York (Clonidine Pill)

Withdrawn
  • Healthy Volunteers
  • Clonidine Pill
  • New York, New York
    Weill Cornell Medicine
Jul 14, 2021

Critical Illness Trial in United Kingdom (Dexmedetomidine, Clonidine, Propofol)

Recruiting
  • Critical Illness
  • Belfast, United Kingdom
  • +43 more
Jan 19, 2023

Nocturia Trial in Birmingham, Atlanta (Behavioral, tamsulosin (alpha-adrenergic antagonist medication), )

Completed
  • Nocturia
  • Behavioral
  • +2 more
  • Birmingham, Alabama
  • +1 more
Sep 9, 2021

Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)

Recruiting
  • Prader-Willi Syndrome
  • +20 more
  • Guanfacine Extended Release
  • Placebo
  • Brooklyn, New York
    Maimonides Medical Center
Dec 20, 2022

ADHD, Autism Spectrum Disorder Trial in Canada, United States (Randomization to either Amphetamine (AMP) class of stimulant

Not yet recruiting
  • ADHD
  • Autism Spectrum Disorder
  • Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication
  • Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
  • Irvine, California
  • +11 more
Jun 14, 2023

Labor Pain Trial (Epidural analgesia with bupivacaine and dexmedetomidine)

Not yet recruiting
  • Labor Pain
  • Epidural analgesia with bupivacaine and dexmedetomidine
  • (no location specified)
Mar 22, 2023

Flushing, Alcohol-Related Disorders, Aldehyde Dehydrogenase Deficiency Trial in San Francisco (Brimonidine Tartrate, Placebo

Completed
  • Flushing
  • +2 more
  • Brimonidine Tartrate
  • Placebo Vehicle Gel
  • San Francisco, California
    UC, San Francisco
Apr 30, 2020